bioRxivMicrobiologyPreprint
Antifungal activity of 2,3-diphenyl-2,3-dihydro-1,3-thiaza-4-ones against two human pathogenic fungi
L. C. Liporagi Lopes, H. F. Sobhi, L. J. Silverberg, R. J. Cordero, A. Casadevall
Abstract
Invasive fungal diseases are prevalent in immunocompromised individuals in whom current therapies often provide suboptimal results. Additionally, the increased resistance to the available antifungal drugs necessitates a search for new compounds. This study reports the antifungal activity of six 5-, 6-, and 7-membered 2,3-diphenyl-2,3-dihydro-1,3-thiaza-4-ones against Lomentospora prolificans and Cryptococcus neoformans. Our data showed that some of the compounds tested had a low MIC and damage on the cell surface of the tested fungal species.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Brilacidin, a novel antifungal agent against Cryptococcus neoformans
Camila Diehl, Camila Figueiredo Pinzan, … Gustavo Henrique Goldman·mBioPeer-reviewed·Jun 25, 2024
- Discovery of New Broad-Spectrum Anti-Infectives for Eukaryotic Pathogens Using Bioorganometallic Chemistry
- In vitro activity of a novel antifungal compound, MYC-053, against clinically significant antifungal-resistant strains of Candida glabrata, Candida auris, Cryptococcus neoformans, and Pneumocystis spp.
G. Tetz, M. Collins, … V. Tetz·bioRxiv·Sep 6, 2018
- Fenbendazole controls in vitro growth, virulence potential and animal infection in the Cryptococcusmodel
H. C. d. Oliveira, L. Joffe, … M. Rodrigues·bioRxiv·Feb 13, 2020
- Amphotericin B Resistance in Lomentospora prolificans is associated with a soluble cell wall component
Nina T. Grossman, Arturo Casadevall·Antimicrobial Agents and ChemotherapyPeer-reviewed·Sep 16, 2026
- Antifungal effects of 3-(4-Phenyl-thiazol-2-yl)-2-thioxo-2, 3-dihydro-1H-quinazolin-4-one against Aspergillus Species
Desh D. Singh, V. K. Tiwari, … Rajesh Dabur·bioRxiv·Oct 22, 2018